Latest AI and machine learning research in oncology/hematology for healthcare professionals.
In medical imaging, challenges are competitions that aim to provide a fair comparison of different methodologic solutions to a common problem. Challenges typically focus on addressing real-world problems, such as segmentation, detection, and prediction tasks, using various types of medical images and associated data. Here, we describe the organization and results of such a challenge to compare mac...
Hepatocellular carcinoma (HCC) is a malignant tumor with high incidence and mortality rates globally, significantly affecting patient prognosis and quality of life. Currently, predicting postoperative recurrence risk and survival in HCC patients remains challenging, as precise and effective quantitative indicators are lacking, limiting clinicians' ability to make individualized treatment decisions...
OBJECTIVES: To develop a deep learning (DL) model for predicting disease-free survival (DFS) in clinical stage I lung cancer patients who underwent su...
BackgroundPatients in palliative care often experience prolonged hospital stays, requiring detailed documentation, complex symptom management, and mul...
Patient outcomes are significantly impacted by the effectiveness and quality of radiation treatment planning. Deep learning, a branch of artificial in...
Ki-67 immunohistochemistry (IHC), a commonly used assay for breast cancer risk prognostication, has significant inter-laboratory heterogeneity. This s...
Artificial intelligence models with biomarkers to predict treatment responses to radiation would be necessary to maximise the treatment outcomes of in...
Extrachromosomal circular DNA (eccDNA) may contribute to genomic rearrangements and tumor heterogeneity, playing a role in cancer development and prog...
Targeted combined immunotherapy (TCI) has shown certain antitumor effects in patients with unresectable hepatocellular carcinoma(uHCC), but only a su...
As a highly prevalent tumor in males, prostate cancer (PCa) needs newly developed biomarkers to guide prognosis and treatment. However, few researche...
INTRODUCTION: Lung neuroendocrine carcinomas (Lu-NECs) are rare, highly aggressive lung tumors with poor prognosis and limited therapeutic options. Un...
Gastric cancer is one of the most common malignant tumors of the digestive system, with a high mortality rate due to late-stage diagnosis. Current cli...
Advances in virtual staining and spatial omics have revolutionized our ability to explore cellular architecture and molecular composition with unprece...
BACKGROUND: Next-generation sequencing (NGS) has become a cornerstone of treatment for lung cancer and is recommended in current treatment guidelines ...
Cytomorphological analysis of the bone marrow aspirate (BMA) is pivotal for the diagnostic workup of a broad range of hematological disorders. However...
Cervical cancer remains a leading cause of cancer-related death among women globally, despite the availability of effective prevention through human p...
PURPOSE: The choice of wound closure modality after limb-sparing extremity soft-tissue sarcoma (eSTS) resection is fraught with uncertainty. Leveragin...
Lung cancer is a major cause of cancer-related deaths, and early diagnosis and treatment are crucial for improving patients' survival outcomes. In thi...
PURPOSE: Patients with head and neck cancer undergoing radiation therapy (RT) may experience pronounced acute skin reactions. We tested whether optica...
Lung cancer is one of the most prevalent malignancies, characterized by high morbidity and mortality rates. Current diagnostic approaches primarily re...